NO304647B1 - (S)-alfa-fenyl-2-pyridinetanamin (S)-malat, farmas÷ytisk preparat inneholde denne forbindelsen og dens anvendelse til fremstilling av legemiddel - Google Patents
(S)-alfa-fenyl-2-pyridinetanamin (S)-malat, farmas÷ytisk preparat inneholde denne forbindelsen og dens anvendelse til fremstilling av legemiddelInfo
- Publication number
- NO304647B1 NO304647B1 NO951546A NO953846A NO304647B1 NO 304647 B1 NO304647 B1 NO 304647B1 NO 951546 A NO951546 A NO 951546A NO 953846 A NO953846 A NO 953846A NO 304647 B1 NO304647 B1 NO 304647B1
- Authority
- NO
- Norway
- Prior art keywords
- malate
- alpha
- phenyl
- pyridinethanamine
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| GB939320273A GB9320273D0 (en) | 1993-04-01 | 1993-10-01 | Compound useful in therapy |
| PCT/GB1994/000651 WO1994022831A1 (en) | 1993-04-01 | 1994-03-29 | (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953846D0 NO953846D0 (no) | 1995-09-28 |
| NO953846L NO953846L (no) | 1995-11-21 |
| NO304647B1 true NO304647B1 (no) | 1999-01-25 |
Family
ID=26302299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951546A NO304647B1 (no) | 1993-04-01 | 1995-09-28 | (S)-alfa-fenyl-2-pyridinetanamin (S)-malat, farmas÷ytisk preparat inneholde denne forbindelsen og dens anvendelse til fremstilling av legemiddel |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0691957B1 (de) |
| JP (1) | JP3023987B2 (de) |
| CN (1) | CN1047168C (de) |
| AT (1) | ATE156813T1 (de) |
| AU (1) | AU682348B2 (de) |
| CA (1) | CA2159478C (de) |
| DE (1) | DE69404974T2 (de) |
| DK (1) | DK0691957T3 (de) |
| DZ (1) | DZ1765A1 (de) |
| ES (1) | ES2105672T3 (de) |
| FI (1) | FI109018B (de) |
| GB (1) | GB9320273D0 (de) |
| GR (1) | GR3025081T3 (de) |
| IL (1) | IL109108A (de) |
| MA (1) | MA23154A1 (de) |
| NO (1) | NO304647B1 (de) |
| PH (1) | PH30950A (de) |
| SG (1) | SG48204A1 (de) |
| WO (1) | WO1994022831A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG52662A1 (en) * | 1988-08-12 | 1998-09-28 | Astra Ab | Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
| ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
| SE9901338D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| SE9901340D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| DE10301650A1 (de) * | 2003-01-17 | 2004-07-29 | Johannes-Gutenberg-Universität Mainz | Medizinisch nützliche 1-Phenyl-2-aminomethylnaphthaline, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung |
| NZ593282A (en) | 2008-12-24 | 2013-06-28 | Astrazeneca Ab | Ethanamine compounds and their use for treating depression |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
| WO1993020052A1 (en) * | 1992-04-03 | 1993-10-14 | Fisons Corporation | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| SG52662A1 (en) * | 1988-08-12 | 1998-09-28 | Astra Ab | Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
| JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
-
1993
- 1993-10-01 GB GB939320273A patent/GB9320273D0/en active Pending
-
1994
- 1994-03-24 IL IL10910894A patent/IL109108A/en not_active IP Right Cessation
- 1994-03-29 WO PCT/GB1994/000651 patent/WO1994022831A1/en active IP Right Grant
- 1994-03-29 AT AT94911232T patent/ATE156813T1/de active
- 1994-03-29 ES ES94911232T patent/ES2105672T3/es not_active Expired - Lifetime
- 1994-03-29 AU AU63802/94A patent/AU682348B2/en not_active Expired
- 1994-03-29 PH PH48016A patent/PH30950A/en unknown
- 1994-03-29 DK DK94911232.0T patent/DK0691957T3/da active
- 1994-03-29 JP JP6521814A patent/JP3023987B2/ja not_active Expired - Lifetime
- 1994-03-29 CA CA002159478A patent/CA2159478C/en not_active Expired - Lifetime
- 1994-03-29 EP EP94911232A patent/EP0691957B1/de not_active Expired - Lifetime
- 1994-03-29 DE DE69404974T patent/DE69404974T2/de not_active Expired - Lifetime
- 1994-03-29 SG SG1996007883A patent/SG48204A1/en unknown
- 1994-03-30 DZ DZ940029A patent/DZ1765A1/fr active
- 1994-04-01 CN CN94103739A patent/CN1047168C/zh not_active Expired - Lifetime
- 1994-04-01 MA MA23459A patent/MA23154A1/fr unknown
-
1995
- 1995-09-28 NO NO951546A patent/NO304647B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954645A patent/FI109018B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402722T patent/GR3025081T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3025081T3 (en) | 1998-01-30 |
| DK0691957T3 (da) | 1997-10-27 |
| MA23154A1 (fr) | 1994-12-31 |
| GB9320273D0 (en) | 1993-11-17 |
| DZ1765A1 (fr) | 2002-02-17 |
| NO953846D0 (no) | 1995-09-28 |
| EP0691957A1 (de) | 1996-01-17 |
| EP0691957B1 (de) | 1997-08-13 |
| PH30950A (en) | 1997-12-23 |
| CA2159478A1 (en) | 1994-10-13 |
| JP3023987B2 (ja) | 2000-03-21 |
| WO1994022831A1 (en) | 1994-10-13 |
| CN1047168C (zh) | 1999-12-08 |
| CN1098095A (zh) | 1995-02-01 |
| NO953846L (no) | 1995-11-21 |
| FI109018B (fi) | 2002-05-15 |
| AU682348B2 (en) | 1997-10-02 |
| FI954645A0 (fi) | 1995-09-29 |
| ES2105672T3 (es) | 1997-10-16 |
| FI954645A (fi) | 1995-11-29 |
| AU6380294A (en) | 1994-10-24 |
| IL109108A (en) | 1999-01-26 |
| JPH08508292A (ja) | 1996-09-03 |
| IL109108A0 (en) | 1994-06-24 |
| ATE156813T1 (de) | 1997-08-15 |
| DE69404974D1 (de) | 1997-09-18 |
| DE69404974T2 (de) | 1997-12-18 |
| CA2159478C (en) | 2005-01-25 |
| SG48204A1 (en) | 1998-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO306725B1 (no) | Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler | |
| WO1994027589A3 (en) | Antidepressant dosage form | |
| NO20063000L (no) | Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav. | |
| NO306235B1 (no) | Anvendelse av et legemiddel for behandling av artritt | |
| NO303116B1 (no) | Forbindelser som kan anvendes for behandling av allergiske sykdommer og betennelsessykdommer, anvendelse av dem, samt farmas÷ytiske blandinger inneholdende dem | |
| MX9604354A (es) | Nueva forma de dosis farmaceutica oral. | |
| NL300258I1 (nl) | Farmaceutische samenstelling voor toepassing in debehandeling van diabetes. | |
| ZA943744B (en) | Therapeutic substituted guanidines | |
| NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
| NO304647B1 (no) | (S)-alfa-fenyl-2-pyridinetanamin (S)-malat, farmas÷ytisk preparat inneholde denne forbindelsen og dens anvendelse til fremstilling av legemiddel | |
| EP0657167A3 (de) | Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingt Störungen, pharmaceutische Zusammensetzungen die Oenothein B enthalten und ein Verfahren zu ihrer Herstellung von Epilobium Parniflorum. | |
| NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
| NO304648B1 (no) | (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel | |
| DK0703781T3 (da) | Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom | |
| NO306162B1 (no) | Antiandrogene forbindelser, promedikament, farmasöytisk preparat og anvendelse av forbindelsene | |
| TH29080A (th) | การบำบัดและป้องกันโรคแพนครีเอติตัส | |
| ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. | |
| IE45454L (en) | Cns-active compositions | |
| UA10108A (uk) | Дитячий лікарський засіб "паравіт", який виявляє жарознижуючу та анальгетичну дію | |
| UA23119A (uk) | Психотропhий засіб | |
| DK67493D0 (da) | Biologisk aktivt produkt og fremgangsmaade til fremstilling deraf samt farmaceutiske og kosmetiske praeparater indeholdende produktet | |
| ITFI930001A1 (it) | Medicamento per il trattamento dell'asma. | |
| NO920031D0 (no) | Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |